Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer CellsSara Häggblad Sahlberg, Marika Nestor|PLoS ONE|2014Cited by 207
Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonistsArun Chandramohan, Anthony W. Partridge, Tsz Ying Yuen et al.|Nature Communications|2024Cited by 40
The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cellsSara Lundsten, Marika Nestor|International Journal of Oncology|2019Cited by 30
Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2Anja C. Mortensen, Marika Nestor|EJNMMI Research|2020Cited by 7
The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer ModelDiana Spiegelberg, Marika Nestor|Frontiers in Oncology|2020Cited by 6